168 related articles for article (PubMed ID: 3776829)
1. Should expiration dates be required on patients' prescription labels?
Hadeler F
Am Pharm; 1986 Aug; NS26(8):30-5. PubMed ID: 3776829
[No Abstract] [Full Text] [Related]
2. Prescription drug products; patient labeling requirements: proposed rule.
Fed Regist; 1979 Jul; 44(131 Pt 2):40015-41. PubMed ID: 10242793
[No Abstract] [Full Text] [Related]
3. Prescription drug products; revocation of patient package insert requirements--Food and Drug Administration. Final rule.
Fed Regist; 1982 Sep; 47(173):39147-55. PubMed ID: 10258154
[TBL] [Abstract][Full Text] [Related]
4. Food and Drug Administration--Prescription drug products; patient package inserts requirements. Final rule.
Fed Regist; 1980 Sep; 45(179 Pt 2):60754-84. PubMed ID: 10248285
[TBL] [Abstract][Full Text] [Related]
5. What drug labels don't tell you.
Consum Rep; 2011 Aug; 76(8):10. PubMed ID: 21770080
[No Abstract] [Full Text] [Related]
6. Use of drugs for unlabeled indications.
Nightingale SL
Am Fam Physician; 1986 Sep; 34(3):269. PubMed ID: 3751849
[No Abstract] [Full Text] [Related]
7. Prescription drugs; revocation of final guideline patient package inserts and withdrawal of draft guideline patient package inserts--Food and Drug Administration. Notice.
Fed Regist; 1982 Sep; 47(173):39249-50. PubMed ID: 10258155
[TBL] [Abstract][Full Text] [Related]
8. The patient package insert--health care provider's friend or foe?
Hirsh HL
Nurs Homes; 1979; 28(4):24-5. PubMed ID: 10283734
[No Abstract] [Full Text] [Related]
9. Invited commentary--prescription drug label adverse events: a call for prioritization: comment on "A quantitative analysis of adverse events and 'overwarning' in drug labeling".
Cheng C; Guglielmo BJ
Arch Intern Med; 2011 May; 171(10):946-7. PubMed ID: 21606102
[No Abstract] [Full Text] [Related]
10. Increasing the odds of patient compliance through prescription warning labels.
Ferguson JM; Discenza R; Miller JA
J Health Care Mark; 1987 Mar; 7(1):37-46. PubMed ID: 10281382
[TBL] [Abstract][Full Text] [Related]
11. Physicians, pharmacists, pharmaceutical manufacturers: partners in patient care, partners in litigation?
Willig SH
Spec Law Dig Health Care (Mon); 1987 Feb; 8(12):7-40. PubMed ID: 10280590
[No Abstract] [Full Text] [Related]
12. FDA proposes more stringent pediatric-use labeling of prescription drug products.
Am J Hosp Pharm; 1993 Jan; 50(1):13, 16. PubMed ID: 8427271
[No Abstract] [Full Text] [Related]
13. Off-label or off-limits?
Ratner M; Gura T
Nat Biotechnol; 2008 Aug; 26(8):867-75. PubMed ID: 18688236
[No Abstract] [Full Text] [Related]
14. Pharmaceutical inserts: legal consequences.
Hirsh HL
Hosp Med Staff; 1979 Jul; 8(7):2-6. PubMed ID: 10242674
[TBL] [Abstract][Full Text] [Related]
15. From off-label prescribing towards a new FDA.
Tabarrok A
Med Hypotheses; 2009 Jan; 72(1):11-3. PubMed ID: 18835103
[TBL] [Abstract][Full Text] [Related]
16. The standardization of expiration-date labels.
Itzchaki S; Lazar E; Deland E
N Engl J Med; 2006 Jun; 354(23):2515-6. PubMed ID: 16760461
[No Abstract] [Full Text] [Related]
17. The variability and quality of medication container labels.
Shrank WH; Agnew-Blais J; Choudhry NK; Wolf MS; Kesselheim AS; Avorn J; Shekelle P
Arch Intern Med; 2007 Sep; 167(16):1760-5. PubMed ID: 17846395
[TBL] [Abstract][Full Text] [Related]
18. Patient package inserts: the proper prescription?
Rowe HM
Food Drug Law J; 1995; 50(1):95-124. PubMed ID: 10342988
[No Abstract] [Full Text] [Related]
19. Rx with a dose of info.
Miller RW
FDA Consum; 1980 Nov; 14(9):22-3. PubMed ID: 10309292
[TBL] [Abstract][Full Text] [Related]
20. Drug promotion.
Kalish RS
N Engl J Med; 1995 Apr; 332(15):1032; author reply 1033. PubMed ID: 7794341
[No Abstract] [Full Text] [Related]
[Next] [New Search]
